Silo Pharma, Inc. has entered into an asset purchase agreement with Many Ads Inc. to acquire the software and domain names associated with the web-based application known as QwikAgents. The transaction, valued at 2.1 million shares of Silo Pharma's common stock, marks a strategic move to enhance the company's digital offerings. The agreement includes customary representations and warranties, as well as indemnification provisions to protect Silo Pharma against any potential misrepresentations or breaches by the seller. This acquisition is expected to bolster Silo Pharma's operational capabilities and expand its market presence in the digital space. The deal is part of Silo Pharma's broader strategy to innovate and enhance its service offerings, positioning the company for future growth in a competitive landscape. The shares issued in this transaction will be unregistered, relying on the exemption provided under Section 4(a)(2) of the Securities Act of 1933. The company plans to file the asset purchase agreement as an exhibit to its current report on Form 8-K, ensuring transparency and compliance with SEC regulations.

Press Release distribution

National Press Distribution across U.S. Media. Direct Access to Key Decision Making Editors.